As the COVID-19 epidemic is gradually spreading in Britain, the British authorities must make an effective response. Therefore, vaccine research is the most important thing, and there is a trace for Oxford University to resume the clinical trial of COVID-19 vaccine at this time. The reason why the clinical trial of COVID-19 vaccine was stopped before was because for the research and development of COVID-19 vaccine, there must be a large number of clinical trials as the basis before it can go on the market. At this time, not many British people are willing to vaccinate COVID-19 vaccine, and there is no way to force vaccination, which leads to the bottleneck in the research and development of COVID-19 vaccine.

If we want to continue to study vaccines, we must have enough public support, but the enthusiasm of the British people is not very high, which is also the main reason for their stagnation. But now the British government has realized the seriousness of the problem, and they want to provide reliable COVID-19 vaccine for Britain through the research of Oxford University, so Oxford University resumed the clinical trial of COVID-19 vaccine in time. According to media reports, about18,000 people have been vaccinated with the experimental vaccine developed by Oxford University. This large-scale clinical trial will certainly cause some discomfort, which will also help Oxford University to improve the vaccine as soon as possible.

Although the experiment has been resumed, it is still unknown when it will be introduced to the market. Britain has been spreading the seriousness of the COVID-19 epidemic to the public, but the British people seem to be more open-minded and less concerned about the COVID-19 epidemic. So is the clinical trial of vaccines in Oxford University. They are not very enthusiastic about vaccine experiments, and some people even believe in the so-called group immunization method. Although there is some scientific truth in group immunization, it is definitely not the first choice at this time. It is the most important thing to develop a vaccine.

At present, Oxford University has not released specific vaccine information, nor has it disclosed the response of volunteers to the outside world. According to this progress, a mature vaccine should be available around 1 1, and the COVID-19 epidemic will be basically solved globally by then.